Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.670
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
2.520
-0.150 (-5.62%)
Pre-market: Apr 29, 2026, 7:42 AM EDT
Spero Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 8.57 | -68.57 | 22.81 | -46.42 | -89.76 | |
| Depreciation & Amortization | - | 0 | 0.37 | 0.87 | 0.65 | |
| Asset Writedown & Restructuring Costs | 0.59 | - | 5.31 | 0.64 | - | |
| Loss (Gain) From Sale of Investments | - | - | - | 0.01 | 0.25 | |
| Stock-Based Compensation | 4.33 | 7.79 | 7.93 | 9.12 | 9.43 | |
| Other Operating Activities | 1.05 | 1.04 | 0.97 | 5.96 | 2.22 | |
| Change in Accounts Receivable | 24.03 | 46.35 | -95.74 | 1.55 | 3.05 | |
| Change in Accounts Payable | -6.61 | 5.93 | 0.76 | -0.48 | -0.05 | |
| Change in Unearned Revenue | -34.66 | -26.63 | 29.01 | 21.89 | 10.64 | |
| Change in Income Taxes | 0.21 | -0.21 | 0.39 | - | 0.78 | |
| Change in Other Net Operating Assets | -10.12 | 10.84 | -4.79 | -0.87 | -1.56 | |
| Operating Cash Flow | -12.62 | -23.44 | -33 | -7.73 | -64.35 | |
| Sale of Property, Plant & Equipment | - | - | - | - | 0.04 | |
| Investment in Securities | - | - | - | 33.81 | 7.63 | |
| Investing Cash Flow | - | - | - | 33.81 | 7.67 | |
| Issuance of Common Stock | - | - | 0.22 | 24.93 | 36.82 | |
| Other Financing Activities | - | - | - | -54.49 | 47.23 | |
| Financing Cash Flow | - | - | 0.22 | -29.55 | 84.05 | |
| Net Cash Flow | -12.62 | -23.44 | -32.77 | -3.48 | 27.38 | |
| Free Cash Flow | -12.62 | -23.44 | -33 | -7.73 | -64.35 | |
| Free Cash Flow Margin | -18.90% | -48.86% | -31.79% | -14.45% | -352.47% | |
| Free Cash Flow Per Share | -0.21 | -0.43 | -0.62 | -0.21 | -2.08 | |
| Cash Income Tax Paid | - | - | 2.21 | - | - | |
| Levered Free Cash Flow | -4.25 | -25.13 | -9.9 | -1.08 | -41.44 | |
| Unlevered Free Cash Flow | -4.25 | -25.13 | -9.9 | 0.55 | -40.22 | |
| Change in Working Capital | -27.16 | 36.28 | -70.38 | 22.09 | 12.86 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.